1. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme. Issue 3 (12th April 2022) Authors: Miehlke, Stephan; Schlag, Christoph; Lucendo, Alfredo J.; Biedermann, Luc; Vaquero, Cecilio Santander; Schmoecker, Christoph; Hayat, Jamal; Hruz, Petr; Ciriza de los Rios, Constanza; Bredenoord, Albert Jan; Vieth, Michael; Schoepfer, Alain; Attwood, Stephen; Mueller, Ralph; Burrack, Sarah; Greinw... Journal: United European Gastroenterology journal Issue: Volume 10:Issue 3(2022) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗